BOSTON June 15, 2019 aibdregionals.com - MASTERING CLINICAL CHALLENGES IN IBD - AIBD Regionals
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
MASTERING ENDORSED BY
THE AMERICAN COLLEGE
CLINICAL OF GASTROENTEROLOGY
CHALLENGES
IN IBD
BOSTON
June 15, 2019
aibdregionals.com
BROUGHT TO YOU BY ADVANCES
IN INFLAMMATORY BOWEL
DISEASES (AIBD) – THE LEADER
IN IBD EDUCATION.
JOIN 600+
INTERDISCIPLINARY
PROFESSIONALS
SHAPING THE FIELD
OF IBD
The AIBD Regionals event
series supplements the
learning at AIBD held
in December every year
featuring brand-new
content.
Presented by leading IBD
experts, you will:
• Discover practical
solutions to mastering
clinical challenges in IBD
• Hear new data and
late-breaking abstracts
• Cover relevant topics
essential to improving
patient outcomes
BOSTON
aibdregionals.com June 15, 2019
LOS ANGELES
Coming to
APRIL 6, 2019 Four Cities
in 2019
WHO ATTENDS
BOSTON
JUNE 15, 2019 A multidisciplinary course
designed for the entire
community of professionals
treating IBD:
Gastroenterologists
Hospitalists
Internal medicine
specialists
CHICAGO Nurse practitioners
JULY 20, 2019 Primary care physicians
Nurses
Pharmacists
Physician assistants
Fellows
Residents
Students
BALTIMORE
SEPTEMBER 7, 2019 Other healthcare
professionals
Meet Our
Co-Chairs
and Faculty
CO-CHAIRS
LOS ANGELES
April 6, 2019
Gil Y. Melmed, MD, MS, FACG
BOSTON
June 15, 2019
Marla Dubinsky, MD
CHICAGO
July 20, 2019
David T. Rubin, MD, FACG
BALTIMORE
Mid-Atlantic IBD Update
September 7, 2019
Millie D. Long, MD, MPH, FACG
Raymond K. Cross, Jr., MD, MS
aibdregionals.com
BOSTON
FACULTY
Ashwin N. Ananthakrishnan, MD, MPH
Massachusetts General Hospital
Harvard Medical School
Boston, Massachusetts
Adam S. Cheifetz, MD, FACG
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, Massachusetts
Marla Dubinsky, MD
AIBD
Icahn School of Medicine at Mount Sinai
REGIONALS
New York, New York BENEFITS:
Francis A. Farraye, MD, MSc, FACG
Boston Medical Center Improves patient
Boston University School of Medicine
Boston, Massachusetts
outcomes
Gil Y. Melmed, MD, MS, FACG
Cedars-Sinai Medical Center
Earn 6.25 CME/CNE
Los Angeles, California credits
Miguel D. Regueiro, MD, FACG
Cleveland Clinic Lerner College of Medicine Convenient 1-day
Cleveland Clinic
Cleveland, Ohio
program
David T. Rubin, MD, FACG
University of Chicago Medicine
Greater access to
Chicago, Illinois nationally renowned
Faculty subject to change
faculty
Networking
opportunities
AGENDA
Session I: New and Emerging Session III: The Role of Infection and
Therapeutic Approaches to IBD Vaccination in the Treatment of IBD
8:30 AM Welcome and Introduction 1:30 PM Pre-activity Knowledge/Competence
Assessment via ARS
8:35 AM Pre-activity Knowledge/Competence
Assessment via ARS 1:35 PM Prevention and Management of
Clostridium difficile Colitis
8:40 AM Keynote: Evolution of Disease
Management in IBD 1:55 PM Vaccinations in IBD: What, When,
and Why?
9:00 AM Recent and Emerging Therapies for CD
2:15 PM Case Study on Infections in IBD
9:20 AM Recent and Emerging Therapies for UC
2:30 PM Post-activity Knowledge/Competence
9:40 AM What Else is New in IBD in 2019? Assessment via ARS
Updates from Latest Guidelines
2:35 PM Panel Discussion
10:00 AM Case Study Around New Therapies
2:45 PM Break
10:15 AM Post-activity Knowledge/Competence
Assessment via ARS
10:20 AM Panel Discussion Session IV: Special Populations
10:30 AM Break 3:10 PM Pre-activity Knowledge/Competence
Assessment via ARS
3:15 PM Treatment Options for Patients With Extra
Session II: Therapeutic Optimization Intestinal Manifestations
10:55 AM Pre-activity Knowledge/Competence 3:35 PM IBD During Pregnancy
Assessment via ARS
3:55 PM IBD in the Elderly
11:00 AM Biosimilars for IBD: Start, Switch,
or Stay Away? 4:10 PM Case Study on Special Patient Populations
11:20 AM Therapeutic Drug Monitoring in IBD: 4:25 PM Post-activity Knowledge/Competence
When, How, and for Which Drugs? Assessment via ARS
11:40 AM Case Study Around Therapeutic 4:30 PM Panel Discussion
Optimization
4:50 PM Take-home Messages
11:55 AM Post-activity Knowledge/Competence
5:00 PM Adjourn
Assessment via ARS
12:00 PM Panel Discussion
12:15 PM Lunch
Agenda subject to change
aibdregionals.com
CONTINUING EDUCATION
Imedex is accredited by the ACCME to provide
continuing medical education for physicians.
In support of improving patient care, this
activity has been planned and implemented by
North American Center for Continuing Medical
Education (NACCME) and Imedex. NACCME is
jointly accredited by the Accreditation Council
for Continuing Medical Education (ACCME),
the Accreditation Council for Pharmacy
Education (ACPE), and the American Nurses
Credentialing Center (ANCC) to provide con-
tinuing education for the healthcare team.
Credit Statements
Physicians: Imedex, LLC designates this live educational activity for
a maximum 6.25 AMA PRA Category 1 CreditsTM. Physicians should
claim only credit commensurate with the extent of their participation
in the activity.
Maintenance of Certification (MOC)
Successful completion of this CME activity
enables a participant to earn up to 6.25 MOC
points toward the American Board of Internal
Medicine’s (ABIM) MOC program. Participants will earn MOC points
equivalent to the amount of CME credits claimed for the activity. It is
Imedex’s responsibility to submit participant completion information
to ACCME for the purpose of granting ABIM MOC points. The deadline
to claim MOC points is June 6, 2019. ABIM Diplomates will be asked to
provide their identification number and date of birth (DOB).
CONFERENCE LOCATION Nursing: This continuing nursing education activity awards 6.25 con-
AND ACCOMMODATIONS tact hours. This activity will also award pharmacotherapeutic contact
hours; however, the final assignment of these contact hours will be
announced once all content has been approved.
Hilton Boston Back Bay Provider approved by the California Board of Registered Nursing,
Provider #13255 for 6.25 contact hours.
40 Dalton Street
Boston, Massachusetts 02115 Pharmacy: This live, knowledge-based activity (Universal Activity
Tel.: (617) 236-1100 Number: JA0006201-9999-19- 009-L01-P) has been approved for a
maximum of 6.25 contact hours (0.625 CEUs).
The certificate is not the official record of your participation in the
activity. The official record of credit will be the information in the CPE
Monitor system. The deadline to claim credit is June 6, 2019 (60 days
from the end of the activity). Following ACPE Policy, NACCME will not
DISCOUNTED ROOM RATE be able to report your claimed credit to CPE Monitor System after
this 60-day period. Eligibility for pharmacy credit is contingent upon
the successful completion of a post-test and/or evaluation for each
$269single/double
activity or session attended.
Physician Assistants: NACCME has been authorized by the American
Academy of PAs (AAPA) to award AAPA Category 1 CME credit for
Hotel Discount Deadline: activities planned in accordance with the AAPA CME criteria. This ac-
tivity is designated for 6.25 AAPA Category 1 credits. PAs should only
May 24, 2019 claim credit commensurate with the extent of their participation.
Who Should Attend
Super Early Onsite
REGISTRATION Saver Bird
This activity is intended for IBD specialists, gastroenterologists, GI
fellows, and other healthcare professionals (internists, primary care
RATES Before 4/13/19– After
physicians, nurse practitioners, physician assistants, nurses, phar-
macists, and others) involved and/or interested in the therapeutic
management of patients with IBD.
4/12/19 5/31/19 5/31/19
Objectives
Physician/PhD/PharmD $89 $99 $119 After successfully completing this continuing medical education
activity, participants should be able to:
NP/PA $59 $69 $79
New and Emerging Therapeutic Approaches to IBD
Nurse/Resident/
Student/Fellow
$49 $59 $69 • Describe the current understanding of IBD pathophysiology
with respect to inflammatory signaling pathways and potential
therapeutic targets
• Evaluate the mechanisms of action and available efficacy and
safety data surrounding new and emerging targeted biologics for
the treatment of IBD
Enter to win three • Apply the latest guideline recommendations and clinical data
to the integration of biologic therapy into the treat-to-target
complimentary hotel nights
approach to IBD
for our AIBD annual event Optimizing Therapy in IBD Management
• Assess disease severity and other patient-specific characteristics
in December if you register that guide treatment choices in IBD management according to
current guidelines
before 4/12/19. • Implement evidence-based approaches for selecting, monitoring,
and adjusting treatment to achieve remission induction and
maintenance in IBD
• Integrate clinical evidence, recent real-world data, current
guidance, and patient preferences into individualized treatment
plans for patients with IBD
11675 Rainwater Drive, Suite 600
Alpharetta, GA 30009, USA
MASTER CLINICAL
CHALLENGES IN IBD
BOSTON
June 15, 2019
REGISTER BY 4/12/19
TO ENTER TO WIN THREE
COMPLIMENTARY HOTEL
NIGHTS AT AIBD 2019
aibdregionals.com
You can also read
